RRAS2 and B-cell chronic lymphocytic leukemia: Interestingly, a time-wise dependence of RRAS2 overexpression is also observed in human patients with full-blown CLL, with overexpression peaking (approximately 30-fold) in the oldest human patients, > 80 years old.